Article Details
Retrieved on: 2024-01-31 13:50:12
Tags for this article:
Click the tags to see associated articles and topics
Summary
The study by Drs. Mayor-Ruiz and Riera unveils a drug, RBS-10, targeting drug-resistant cells via the enzyme NQO1, presenting an innovative strategy to combat cancer treatment resistance.
Article found on: www.eurekalert.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here